Home Earnings Accolade Inc. Earnings Preview: What to Expect From Earnings

Accolade Inc. [ACCD] Earnings Preview: What to Expect From Earnings

Accolade Inc. [NASDAQ:ACCD] will report earnings after markets close on Thursday, January 7th.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

ACCD Earnings Forecast For The Current Quarter

Accolade Inc. [ACCD] is expected to report earnings results for the quarter ending on Nov 2020. Consensus estimates give the company expected revenues of $36.19M and an earnings per share of -$0.35 for Nov 2020. Looking further ahead, the company is expected to report revenue of $51.6M at an EPS of -$0.13 for Feb 2021. The estimates represent 24.60% and 60.20% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


ACCD Earnings Estimates For The Current Year

For the financial year, Accolade Inc. [NASDAQ:ACCD] is expected to bring in revenue of $159.78M. The returns are nearly $27.27 million higher than the company’s actual revenue recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at -1.86. As for sales, forecasts are for an increase of 20.60% in the current fiscal year and a further 24.60% over the following year.

ACCD Price Performance

On Wall Street, Accolade Inc. [NASDAQ:ACCD] finished Tuesday’s session up 2.63% at $42.54. The stock went up to $42.81 at the same session while its lowest single day price was $39.65. In the last five days, it saw a fall of about -10.14%, Accolade Inc. shares dropped by almost -2.21% since the beginning of the year. However, the share price has dropped to as low as -34.80% below its one year high.

ACCD Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 40.52 level, and in case of violation of this particular level, it will cause more drop to 38.51 level. On the upper level, 44.83 is still the key resistance. The stock may increase to the subsequent resistance at 43.68. The Relative Strength Index (RSI) pinned on the 14-day chart is 39.59, implying a neutral technical stance while the MACD stands at -6.18, meaning price will decrease in the next trading period. Percent R indicator moved to 84.47%, implying bearish price movement. Stochastic %K at 8.23% suggest buying the stock.

What is the short interest in Accolade Inc.?

Short interest in the Accolade Inc. stock has plunged, decreasing by -0.13 million shares to total 3.05 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.92 million, data from Yahoo Finance shows. The increase of 4.26% suggests the stock saw some increased bearish sentiment. The stock’s days to cover moved to short ratio while the shorted shares account for just 8.85% of the overall float for the stock.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What are analyst thoughts on Accolade Inc.?

Looking forward to the Accolade Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Accolade Inc. stock at $49.50 within the next 12 months, which represents almost 14.06 per cent growth from its previous closing price of $42.54. The highest analysts’ target for Accolade Inc. stock projections is $59.00 and the lowest one is $42.00. Still, 11 analysts sharing their consensus rating for ACCD stock in 2021 agree that it is a Buy.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

FireEye, Inc. (FEYE) Stock Trends Up After Being Enlisted by Colonial Pipeline After Cyberattack

FireEye, Inc. (FEYE) stock prices were up 5.41% earlier in the trading day on May 10th 2021, bringing the price per share up to...

ChemoCentryx Inc. (CCXI) (NASDAQ:CCXI) stock plunged in the premarket trading session; here’s why

At last check, in the premarket trading session ChemoCentryx Inc. (CCXI) shares plunged by-62.50% to $10.31. CCXI's stock closed the previous session at $27.49....

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Alfi inc. (NASDAQ:ALF) stock surged in the current trading session; here’s why

In the current trading session, ALF stock had surged by 8.54% to trade at the price of $3.88 at the time of writing. The...

Why The Petco (WOOF) Stock Has Been Moving Upwards Today?

Stock of Petco Health and Wellness Company (NASDAQ: WOOF) has just started getting traction in pre-hours trades today. With over 1.59 million Petco stock...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam